We have determined the 679 nucleotide sequence of a cDNA clone which, by hybridization-translation experiments, corresponds to a 36K chick brain protein. Our studies provide a partial amino acid sequence for this protein, identifying it as chicken glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Antisera raised against purified chicken GAPDH reacted with a 36K protein present in chick brain extractsand estimated to be the fourth most prevalent protein, as determined by either Coomassie Blue staining or by in vitro translation of chick brain mRNA. The amounts of GAPDH mRNA in chick brain, liver and muscle and adult chicken brain are similar, whereas the relative amount of adult chicken muscle GAPDH mRNA is greatly elevated and that of adult liver lowered. The GAPDH protein levels showed a similar variation between tissues, suggesting that the levels of GAPDH protein are largely regulatedby the amount of available GAPDH mRNA. The chicken GAPDH clone does not hybridize to rat mRNA, even though GAPDH is one of the most evolutionarily conserved proteins, indicating that selection pressures are heavier at the primary protein sequence level than at the nucleic acid sequence level for this gene, a situation contrasting to that of the tubulins.
INTRODUCTION
The developing chick brain expressed a number of abundant messenger RNA species, including mRNAs coding for tubulin and actin. We and our colleagues have generated cDNA clones corresponding to the mRNAs for actin and a and a tubulin and have shown these to be the three most abundant mRNA species in the developing chick brain (1) (2) (3) . In the course of these studies, other abundant mRNAs have been cloned. We initially intended to use one of these, clone p13, corresponding to a prevalent chick brain mRNA to monitor our cloning of cDNA copies of rat brain specific mRNA. However, p13 did not hybridize in Northern blots to any rat mRNA species. We were curious as to the identity of a major avian brain mRNA species which had no homologue in the mRNA of amammal,andso determined the nucleotide sequenceof the cloned cDNA. The nucleotide sequence contained a long open triplet reading frame which, when translated, was found to encode the N-terminal two-thirds of the Nucleic Acids Research glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Further studies with the cDNA clone and an antibody to purified chicken GAPDH show that both the mRNA and orotein are abundantly exnressed in the brain, liver and muscle of 17 day embryos. In the adult chicken, however, in the same three tissues there is a substantial regulation of the expression of GAPDH mRNA and protein.
EXPERIMENTAL p13 represents chicken GAPDH mRNA
The cDNA clone p13 was constructed (2) by oligo dT priming the reverse transcription of polyA+ RNA from chick embryo brain, followed by treatment with DNA polymerase I and Si nuclease. The resulting double stranded cDNA was ligated to HindIII linkers, cleaved with the restriction endonuclease HindIII, and cloned in the HindIII site of pBR322.
We characterized the protein encoded by the cloned mRNA using a hybridization-translation assay (2) . Chick embryo brain polyA+ RNA was hybridized to p13 DNA bound to nitrocellulose filters. After extensive washing, the specifically bound RNA was released and used to program an in vitro translation system and the 35S-methionine labeled products were analyzed by SDS-polyacrylamide gel electrophoresis ( Fig. 1) . Unfractionated amino acids of GAPDH. Their sequence overlaps our sequence by 90 nucleotides and the overlapping regions of the two nucleotide sequences are identical. In both cases the derived amino sequences of the overlapping region include one residue which differs from the sequence of the pig enzyme. Together these two sequences provide the complete primary structure of chicken GAPDH. The nucleotide sequence corresponding to the carboxy terminal region of GAPDH (7) shows a site for the restriction enzyme HindIII in the position of the HindIII site which terminates our sequence indicating that the cDNA which gave rise to clone p13 was probably cleaved at this position by the HindIII treatment used in construction of the clone.
GAPDH mRNA Is the Fourth Most Abundant Message in Chick Brain
Since p13 represents the mRNA for GAPDH, a 36K protein, and since the fourth major translation product of chick brain mRNA has a molecular weight of 3f,O000, we suspected the two were identical. We purified GAPDH antiserum was used to probe a Western Blot (10) (Fig. 3) on which the purified chicken GAPDH and chick brain protein extract had been separated, the antibody reacted with the chicken GAPDH, as expected. Additionally, it reacted with a 36K species in the chick brain which comigrated with the fourth major protein species as visualized by Coomassie Blue stain. Both of these have the same mobility as commercial rabbit GAPDH, which, of course, does not react in the Western because of immunological self-tolerance--the antiserum was raised in rabbit.
To confirm the identity of GAPDH and the 36K chick brain translation product, we translated unfractionated chick brain polyA+ RNA in vitro, imnunoprecipitated the products with rabbit anti-GAPDH or normal rabbit serum, and analyzed the supernatants by gel electrophoresis (Fig. 4) . Rabbit anti-GAPDH but not normal rabbit serum removed the majority of the 36K product from the gel profile, indicating that the major species is indeed GAPDH. Therefore, the fourth major chick brain mRNA codes for GAPDH. GAPDH mRNA Is Regulated During Chicken Development
We used p13 DNA as a hybridization probe for Northern blot analysis (11) of the total cytoplasmic RNA of various chicken and rat tissues, including developing chick brain from 17 day eggs. p13 hybridizes toa chick brain RNA species with gel mobility of about 1400 nucleotides, a length quite suffi- Figure 3 . The photograph was cut to show the 36K region.
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GAPDH Protein Concentration Reflects GAPDH mRNA Concentration
Since GAPDH mRNA appears to be dramatically regulated in adult chickens, we investigated the levels of GAPDH protein in those tissues and in the translation products of the polyAt RNA from each tissue. Figure 6 shows the in vitro translation patterns of the RNA from each tissue. The levels of the major 36K protein species seem to mimic the levels of GAPDH mRNA in these tissues (Fig. 5) . The Figure 7 shows the Coomassie Blue stained SDS-polyacrylamide gel protein profile of brain, liver and muscle extracts from both chick embryo and adult. The patterns show some similarity to the protein profiles of Figure 6 , but there are also many differences. The major 36K species has the same tissue distribution in the dissected tissues as GAPDH mRNA analyzed on Northern blots in brain and muscle. Both adult and chick liver seem somewhat elevated in the 36K species compared to the mRNA levels in those tissues. Western blotting (Fig. 7B) of the same extracts with the anti-GAPDH serum follows the same profile as the major 36K species.
GAPDH activity has been measured in extracts of rat tissues (12) and is found in the ratio 81:63:294 for brain, liver and muscle. Given the species difference and the clear age dependence of the regulation in chicken, these values seem to be generally compatible with our measurements.
DISCUSSION
We have identified a major mRNA of developing chick brain as coding for the glycolytic enzyme GAPDH. The identity of the mRNA corresponding to clone p13 was determined unambiguously from the clone's nucleotide sequence: an amino acid sequence translated from the only open triplet reading frame showed 90% homology with the known sequence of GAPDH from the pig. Further experiments using both the clone and anti-GAPDH antibodies demonstrate that GAPDH and its mRNA are abundant species in the brain of the chick embryo.
Our sequence does not provide an N-terminus for the primary translation product of GAPDH mRNA or for mature chicken GAPDH (which, in fact, DNA sequencing cannot provide). Two observations seem appropriate. Because the HindIII site at the N-terminal end of the sequence was not perfectly formed, as would have been expected had cloning gone exactly as designed, the 5' sequence must be regarded as potentially unfaithful until it becomes synchronous with other GAPDH sequences (9 nucleotides). Second, there is a precedent for variable N-terminal extensions of GAPDH as evidenced by the recently determined human GAPDH sequence (13) . Our sequence is best characterized as providing suggestive, but not necessarily unequivocal, evidence that the chicken GAPDH primary translation product is N-terminally extended compared to the mature pig GAPDH sequence.
Our studies provide a large portion of the amino acid sequence of quences of GAPDH from pig, lobster, yeast and two species of bacteria (Fig.  8) . The number of differences in amino acid residues between these sequences correlate well with the evolutionary relationships of the various species. That is, chicken GAPDH is most closely related to pig GAPDH and the chicken and pig enzymes show almost equal divergences from GAPDH of lower organisms. Nevertheless, this is one of the most highly conserved of proteins, retaining 50% sequence identity over long eons of evolution, equivalent to a mutation rate of 2.2 PAMs (accepted point mutations) per 100 million years (14) . This preservation of structure has been previously described (15) That an enzyme should be encoded by such an abundant mRNA in the chick embryo brain was a considerable surprise--we had anticipated that the major 36K protein would be structural, as are actin and the tubulins. We therefore examined the expression of GAPDH mRNA and protein in other tissues of adult and embryonic chickens. To assess the protein, we produced an antibody 3312 against purified chicken GAPDH. In 17 day chick embryos there are approximately equal amounts of both GAPDH and GAPDH mRNA in brain, liver and breast muscle. In the same tissues in adult chickens, however, there is a considerable variation in the levels of both protein and mRNA: relative to the amounts in the embryo, brain is approximately unchanged, liver is decreased and muscle is increased. The same changes are seen when GAPDH mRNA levels are quantitated directly by Northern blotting or indirectly by in vitro translation and when GAPDH protein levels are examined by staining. In brain and muscle at the two ages there is a good correlation between the concentration of GAPDH protein and its mRNA, suggestive that the molecular basis for regulating the amount of GAPDH protein in different tissues is by controlling the steady state levels of cytoplasmic GAPDH mRNA. This could operate at the level of transcription or RNA processing and degradation, or all of these. In liver, particularly in the adult, there is rather more GAPDH protein present than would be predicted from the amount of GAPDH mRNA, sugges In the liver, however, there is a considerable decrease in GAPDH content in the adult relative to the embryo. Measurements of GAPDH enzyme activity during development show a similar pattern: a rise in activity peaking at 18 embryonic days, dropping 3-4 fold thereafter to the level of the adult (18) .
The increase in enzyme activity correlates well with the time course of glycogen deposition in the liver (19) , suggesting that in the embryonic liver GAPDH may function largely in the direction of gluconeogenesis using carbohydrate or, more likely, amino acid precursors. Other glycolytic enzymes follow similar activity time courses as GAPDH during development (18) .
Immediately after hatching, the glycogen stores of the embryo, mainly in the liver, are rapidly depleted, indicating a massive release of glucose. GAPDH activity shows a similar rapid decline after hatching to the lower levels of the adult. This activity is probably sensitive to diet and the low levels of GAPDH in the adult may be related to special feeds which promote egg laying. In the embryo, however, where diet is of no importance, the high levels of GAPDH may not only be a consequence of the metabolic demands of the embryo but perhaps also a preparation for the nutritional changes that occur after hatching.
For this study it was useful to produce an antibody to the protein product corresponding to theclonedmRNA. In this particular case, the preparation of the enzyme was simple and efficient because the sequence matched an already known and well characterized protein. In other cases, however, particularly when the cloned gene product is unknown, it might be necessary to adopt an alternative strategy and generate appropriate antibodies directed against short synthetic peptide fragments of the protein sequences (20) .
